IVF Advances in Mexico and Colombia: Encouraging News for Intended Parents
For people who have spent years hoping, waiting and searching for another path to parenthood, every meaningful advance in fertility care represents something deeply personal: possibility.
Mexico and Colombia are receiving growing attention for their roles in assisted reproduction. A major regional report released in 2026 documented decades of IVF-related births, while recent developments in reproductive laboratory standards and fertility technology offer further reasons for optimism.
These advances do not guarantee that an individual IVF treatment or embryo transfer will succeed. However, they show that both countries are contributing to the continued development of fertility care in Latin America—encouraging news for intended parents exploring surrogacy programs in Mexico and Colombia.
Quick answer: What is the latest positive fertility news from Mexico and Colombia?
The 2026 report from the Latin American Network of Assisted Reproduction, known as REDLARA, recorded 61,402 babies born in Mexico and 14,033 in Colombia through assisted reproductive technologies between 1990 and 2023. Colombia also reached a reported reproductive-laboratory accreditation milestone in 2026, while Mexico was the location of a world-first live birth following digitally controlled, remotely operated ICSI reported in 2025.
These figures relate to assisted reproduction generally; they are not Atlas Surrogacy results and should not be described as surrogacy success rates.
More Than 75,000 Assisted-Reproduction Births Recorded in Mexico and Colombia
In 2026, REDLARA presented an analysis of 33 years of voluntarily reported data from fertility centres across Latin America. The registry covered the period from 1990 through 2023 and included:
More than 1.5 million initiated assisted-reproduction cycles across Latin America
342,268 babies born through assisted reproductive technologies in the region
61,402 reported births in Mexico
14,033 reported births in Colombia
Together, Mexico and Colombia accounted for more than 75,000 reported births through assisted reproduction during the period covered.
The numbers demonstrate the substantial history of IVF and related fertility treatments in both countries. However, they are cumulative registry figures, not a prediction of what will happen during a particular IVF or surrogacy journey. REDLARA also notes that its historic data are based on voluntary reporting, so the figures should be presented with that context.
The report discusses important regional developments in embryo culture, frozen embryo transfer, preimplantation genetic testing and elective single embryo transfer. Its central message is encouraging but responsible: strong laboratory conditions and evidence-based embryo-transfer practices can help fertility programmes pursue both effectiveness and safety.
Why Single Embryo Transfer Is an Important Sign of Progress
One positive trend highlighted by REDLARA is the growing focus on transferring one embryo at a time when medically appropriate.
The aim of fertility treatment is not simply to achieve a positive pregnancy test. The greater goal is a healthy pregnancy and the birth of a healthy baby. Multiple pregnancies can carry increased risks, which is why experienced fertility specialists may recommend elective single embryo transfer based on the patient’s circumstances and embryo quality.
REDLARA’s 2026 presentation concludes that good laboratory conditions, effective embryo culture and reliable cryopreservation can support single embryo transfer while maintaining a thoughtful balance between safety and effectiveness.
Every treatment decision must be made by an independent fertility specialist after reviewing the intended parents’ medical circumstances. Still, the regional emphasis on safer, evidence-based practices is good news for families researching IVF and surrogacy in Latin America.
Colombia Reaches a Reproductive-Laboratory Milestone
Colombia has also received positive attention for the continued development of its reproductive-medicine laboratories.
In July 2026, a Colombian publication reported that Babynova Clinic Fertility & Genetics Center held current accreditation through the College of American Pathologists’ Reproductive Accreditation Program. According to that report, it was the only fertility-centre laboratory in Latin America holding that particular current accreditation at the time of publication.
The College of American Pathologists developed its reproductive accreditation programme for the specialized requirements of fertility laboratories. The program addresses areas such as:
Identification and handling of eggs, sperm and embryos
Specimen labelling and traceability
Cryogenic storage conditions
Risk reduction and quality control
Embryologist training and continuing competency
Peer inspection and ongoing improvement
Accreditation does not guarantee an individual clinical outcome, and it should not be interpreted as applying to every fertility centre in Colombia. Nevertheless, the milestone reflects the increasing attention being given to internationally recognised laboratory processes within the country’s fertility sector.
This matters because embryologists perform highly specialised work throughout IVF—from handling eggs and sperm to fertilization, embryo culture, vitrification and preparation for embryo transfer.
Learn more about the College of American Pathologists’ Reproductive Accreditation Program and the reported 2026 fertility-laboratory milestone in Colombia.
Intended parents considering a journey in Bogotá can also explore Atlas’s overview of surrogacy in Colombia.
Mexico Was Home to a World-First IVF Achievement
Mexico has also played a role in one of the most fascinating recent developments in reproductive medicine.
In 2025, researchers published a case report describing the first live birth following fertilization with a digitally controlled, remotely operated intracytoplasmic sperm injection system. The procedure took place at a fertility centre in Guadalajara, Mexico.
Intracytoplasmic sperm injection, commonly called ICSI, is an IVF technique in which a single sperm is injected directly into an egg. Fertility specialists may consider it in cases involving male-factor infertility or previous fertilization difficulties.
In the reported case, computer-controlled technology and artificial intelligence supported several precise stages of the process. Four of five injected eggs fertilized normally. A later frozen embryo transfer resulted in an uncomplicated pregnancy and the birth of a healthy baby boy at 38 weeks.
This was one clinical case. Its 80% fertilization result must not be presented as a general IVF success rate, and the researchers noted that further evidence is required to determine the technology’s wider clinical benefits.
Even with that necessary caution, the achievement demonstrates that Mexico is contributing to international fertility research and the future development of IVF laboratory technology.
Read the scientific case report, A Digitally Controlled, Remotely Operated ICSI System: Case Report of the First Live Birth.
To learn more about family-building options in Mexico, visit Atlas’s guide to Mexico surrogacy program
What Do These IVF Advances Mean for Surrogacy?
In a gestational surrogacy journey, IVF is used to create an embryo before it is transferred to a surrogate. Fertility-clinic and laboratory stages can therefore be important parts of the overall process.
Recent developments in Mexico and Colombia demonstrate growing regional experience with areas including:
IVF and ICSI
Egg donation
Embryo culture and assessment
Vitrification and embryo storage
Frozen embryo transfer
Laboratory traceability and quality systems
Safer embryo-transfer strategies
These developments are encouraging, but IVF outcomes remain highly individual. Factors such as age, egg and sperm quality, embryo development, medical history, treatment protocol and the use of donor eggs can influence the chance of success.
No technology, fertility clinic, agency or program can promise that a specific embryo transfer will result in pregnancy or live birth. Intended parents should request individual guidance from qualified medical professionals and avoid comparing their journey with a broad regional statistic.
Families who may need donor eggs can learn more through Atlas’s egg donation information.
Questions Intended Parents Should Ask Before Starting
Positive fertility news can offer hope, but every family still needs an individual plan. Before selecting a fertility clinic or beginning a surrogacy journey in Mexico or Colombia, consider asking:
What experience does the fertility clinic have?
Ask about the clinic’s experience with IVF, ICSI, egg donation, embryo freezing and patients pursuing surrogacy.
How does the clinic calculate its success rates?
Request data that are relevant to your age, treatment type, embryo source and medical circumstances. Pregnancy rate, live birth rate and cumulative live birth rate are different measurements.
What laboratory safeguards are followed?
Ask how eggs, sperm and embryos are identified, handled, monitored, stored and traced throughout treatment.
Who provides each professional service?
Understand the separate roles of the fertility clinic, surrogacy coordinator, independent attorney, psychologist and other professionals involved.
What happens if an embryo transfer is unsuccessful?
Ask about possible medical next steps, remaining embryos, expected additional costs and how another transfer would be coordinated.
Frequently Asked Questions
Is IVF available for surrogacy journeys in Mexico and Colombia?
Yes. Gestational surrogacy requires IVF to create an embryo before transfer to a surrogate. The exact medical plan must be developed with an independent fertility clinic and physician.
Are the REDLARA numbers surrogacy success rates?
No. The figures are cumulative assisted-reproduction births reported voluntarily by participating fertility centres between 1990 and 2023. They include IVF and other assisted reproductive technologies and are not Atlas Surrogacy statistics.
What affects IVF success in Mexico or Colombia?
IVF outcomes may be affected by age, egg and sperm quality, embryo development, medical history, laboratory practices, treatment protocol and whether donor eggs are used. Intended parents should request personalized information from their fertility specialist.
Does new IVF technology guarantee pregnancy?
No. New technology may support research, consistency or laboratory processes, but it cannot guarantee fertilization, pregnancy or live birth. The Mexico achievement discussed in this article was a single published clinical case.
Can international intended parents explore Atlas programmes?
Atlas Surrogacy works with intended parents exploring family-building options in Mexico and Colombia. Eligibility, medical planning and legal considerations depend on the circumstances of each family and must be reviewed with the appropriate independent professionals.
How does Atlas Surrogacy support intended parents?
Atlas helps intended parents understand and coordinate the stages of a surrogacy journey and connects them with independent medical, legal and other professional providers. Atlas does not provide medical, legal or psychological services.
Explore Surrogacy in Mexico and Colombia With Atlas
Behind every statistic is a family that once wondered whether parenthood would be possible.
The latest regional data and scientific developments offer genuine reasons for hope. They also reinforce the value of careful planning, transparent information, qualified professionals and individual medical guidance.
Atlas Surrogacy helps intended parents explore and coordinate surrogacy journeys in Mexico and Colombia, including connections with independent fertility, legal and other professional providers.
Are you ready to understand which options may be available for your family?
You can also learn more about Atlas Surrogacy or contact the Atlas team.
Disclaimer: This article is provided for general informational purposes only. Atlas Surrogacy does not provide medical, legal or psychological services. Fertility outcomes vary, and no individual result is guaranteed. Intended parents should obtain advice from qualified independent professionals before making medical or legal decisions.
Source references for the publisher
Latin American Registry of Assisted Reproduction, “Aprendiendo de Big Data: 35 años del Registro Latinoamericano de Reproducción Asistida,” presented in 2026, covering registry data from 1990–2023: https://redlara.org/images/arquivo/ConferenciainauguralREDLARA2026.pdf
College of American Pathologists, Reproductive Accreditation Program: https://www.cap.org/laboratory-quality-solutions/accreditation/reproductive-accreditation-program/
Zona Bien, report on reproductive laboratory standards and accreditation in Colombia, July 23, 2026: https://www.zonabien.info/2026/07/23/en-el-dia-mundial-del-embriologo-la-experiencia-y-los-estandares-internacionales-fortalecen-la-medicina-reproductiva-en-colombia/
Mendizabal-Ruiz G, Chavez-Badiola A, Hernández-Morales E, et al. “A digitally controlled, remotely operated ICSI system: case report of the first live birth.” Reproductive BioMedicine Online. 2025. https://doi.org/10.1016/j.rbmo.2025.104943
Comments